Workflow
低位景气成长赛道
icon
Search documents
创业板指震荡调整,关注创业板ETF(159915)等产品配置机遇
Sou Hu Cai Jing· 2025-10-14 10:49
Group 1 - The ChiNext Mid-Cap 200 Index fell by 2.6%, the ChiNext Index decreased by 4.0%, and the ChiNext Growth Index dropped by 4.6% [1] - Over the last three trading days, the ChiNext ETF (159915) saw a net inflow exceeding 2 billion yuan, bringing its latest scale to over 106 billion yuan [1] - CITIC Securities indicated that after concentrated trading in the computing power sector, market funds are gradually shifting towards other low-valuation growth sectors, suggesting a potential continuation of a slow bull market [1] Group 2 - In the context of a macroeconomic environment that has not fully recovered, structurally prosperous new sectors are expected to be key investment opportunities [1] - Focus areas include sectors with concentrated catalytic events such as semiconductors, new energy, humanoid robots, innovative pharmaceuticals, and non-ferrous metals [1]
中信建投证券:持股过节性价比高 中期市场或延续慢牛格局
Xin Hua Cai Jing· 2025-09-29 03:36
Group 1 - The core viewpoint is that the National Day holiday typically sees liquidity contraction, which is often characterized as "emotional shrinkage" rather than a fundamental issue [1] - Historically, the market tends to experience a "post-holiday rally," with sustained gains in bull markets, especially when long holidays coincide with positive events [1] Group 2 - Recent market focus has shifted towards domestic policies and structural industry prosperity, with less attention on US-China relations, although there are signs of improvement in the latter since September [2] - Market funds are transitioning from concentrated trading in the computing power sector to other low-position growth sectors, indicating a potential continuation of a slow bull market [2] - In the context of a macroeconomic environment that has not fully recovered, sectors with structural prosperity are expected to be key investment areas, particularly in semiconductors, new energy, humanoid robots, innovative pharmaceuticals, and non-ferrous metals [2]